B

BridgeBio

Develops therapies for genetic diseases

Senior Director - GTM Strategy & Portfolio Planning

Product MarketingConfirmed live in the last 24 hours
Full-timeSan Francisco, CA, USA

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 12 years of commercial biotech or pharmaceutical experience, including at least 7 years in marketing, go-to-market, or portfolio strategy roles.
  • Rare disease launch and go-to-market strategy experience is required.
  • Experience building portfolio planning frameworks, resource allocation models, or franchise-level prioritization across multiple assets is required.
  • Ability to align marketing, medical, access, and research and development stakeholders around a shared strategy in a pre-launch, high-ambiguity environment is required.
  • Ability to travel approximately 25% for key congresses, advisory boards, and field engagement is required.
  • Demonstrated curiosity and adaptability in adopting artificial intelligence-powered tools and technologies is required.

Responsibilities

  • Own the end-to-end go-to-market strategy for encaleret, including market entry sequencing, positioning, and the long-range commercial roadmap from pre-New Drug Application approval through Year 1 and beyond.
  • Lead marketing portfolio planning across BridgeBio’s endocrine pipeline, building the framework used to prioritize investment, sequence launches, and allocate commercial capacity across current and future assets.
  • Serve as the senior commercial strategist on the encaleret Product Team, embedding market, competitive, and portfolio insight into cross-functional planning with Medical Affairs, Regulatory, Market Access, Research and Development, and Patient Advocacy.
  • Partner with Value & Access and Finance to align long-term payer strategy, forecasting, and lifecycle planning with the broader endocrine portfolio roadmap.
  • Partner with HCP Marketing, Patient Marketing, and KOL Engagement to translate go-to-market and portfolio strategy into coordinated field execution, serving as the strategic through-line across these teams without direct management authority.
  • Build and govern the competitive intelligence, market research, and forecasting infrastructure that informs encaleret’s launch strategy and portfolio-level decision-making.
  • Develop and present long-term go-to-market and portfolio strategy updates to senior leadership and the Board of Directors.

Desired Qualifications

  • An MBA or advanced science degree is preferred.
  • Endocrinology or nephrology experience is a significant differentiator.

About the Company

BridgeBio

Develops therapies for genetic diseases

BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at BridgeBio

See more jobs